{"id":"W4233825533","doi":"10.4161/cbt.6.3.4165","title":"Clinical Benefit of Antisense Therapy in a Phase III Trial in Patients with CLL","year":2007,"lang":"en","type":"article","venue":"Cancer Biology & Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fludarabine; Chronic lymphocytic leukemia; Chemotherapy; Oncology; Internal medicine; Clinical trial; Cancer; Leukemia; Population; Cyclophosphamide","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001107092,0.0001781667,0.0007396815,0.0002442139,0.00001721778,0.000002716599,0.0001533325,0.0002907583,0.000201029],"category_scores_gemma":[0.00004445056,0.0001195077,0.00009776044,0.0004255502,0.0004139983,0.00003259894,0.00002184555,0.0003441076,0.000003154259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00170066,"about_ca_system_score_gemma":0.002210413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00137656,"about_ca_topic_score_gemma":0.0005886633,"domain_scores_codex":[0.9980112,0.0001223436,0.0007674712,0.0004097821,0.0001992136,0.0004900433],"domain_scores_gemma":[0.9988489,0.0003170087,0.0001737447,0.0003947134,0.0001463739,0.0001192731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3953651,0.001853866,0.3694881,0.000007554101,0.0001264736,0.00004342156,0.0003004963,0.000001953209,0.001157438,0.00003128968,0.00004390442,0.2315805],"study_design_scores_gemma":[0.802548,0.01177636,0.1802675,0.00009429749,0.000007959341,0.000003152057,0.00003175562,0.00004387605,0.002531178,0.00005953645,0.002501318,0.0001351252],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958234,0.001973724,0.00001698933,0.0001214087,0.0002822894,0.001606383,0.00001854942,0.00001470933,0.0001425153],"genre_scores_gemma":[0.9936053,0.005200373,0.00008508407,0.0006668269,0.000264017,0.00005555147,0.00003670561,0.0000257568,0.00006039013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4071829,"threshold_uncertainty_score":0.4873383,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05949674630688416,"score_gpt":0.4390387247558386,"score_spread":0.3795419784489544,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}